Chori (8014) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
21 Jul, 2026Executive summary
Achieved record highs in ordinary profit (¥8.6B), profit before income taxes (¥9.3B), and net profit attributable to owners of parent (¥7.0B) for Q2 FY03/2025, with all segments posting increased profit year-over-year.
Net sales rose to ¥154.5B (+1.0% YoY), with steady progress in line with the business results forecast and the medium-term management plan.
Operating profit declined 5.3% YoY to ¥7.4B due to higher SG&A expenses.
Business transformation project (SAP implementation) is progressing as planned, with personnel training underway for full-scale operation from FY2025.
Selected for the first time as a component of the JPX-Nikkei Mid and Small Cap Index.
Financial highlights
Net sales: ¥154.5B (+1.0% YoY); Gross profit: ¥20.4B (+5.5% YoY).
Ordinary profit: ¥8.6B (+12.3% YoY); Profit before income taxes: ¥9.3B (+19.9% YoY); Net profit: ¥7.0B (+40.2% YoY).
Comprehensive income for the period was ¥8.2B, up 7.9% YoY.
Basic earnings per share rose to ¥285.61 from ¥204.04 a year earlier.
Equity ratio improved to 61.5% from 57.2% at the previous fiscal year-end.
Outlook and guidance
FY03/2025 forecast: Net sales ¥320.0B, operating profit ¥15.0B, ordinary profit ¥15.0B, profit before income taxes ¥15.0B, net profit ¥10.0B, basic EPS ¥405.82.
Expectation of record-high profit before income taxes and net profit for the full year.
No changes to previously announced forecasts; actual results may vary due to external factors.
Latest events from Chori
- Profits and sales rose sharply, led by Chemicals, with double-digit growth forecast for FY2027.8014
Q1 202730 Jul 2026 - Record Q1 profits, improved equity ratio, and strong progress on business transformation.8014
Q1 202521 Jul 2026 - Net profit attributable to owners of parent increased 13.1% year-over-year to ¥9,123 million.8014
Q3 202521 Jul 2026 - Record profits and higher dividends achieved, with stable outlook amid global uncertainties.8014
Q4 202521 Jul 2026 - Sales and profits fell YoY, but gross margin improved and full-year guidance is unchanged.8014
Q1 202621 Jul 2026 - Profits and sales fell YoY, but gross margin, financial stability, and guidance were maintained.8014
Q2 202621 Jul 2026 - Profits and sales fell YoY, but full-year guidance and dividend forecast were raised.8014
Q3 202621 Jul 2026 - Net profit rose 3.0% despite lower sales, with a higher dividend payout ratio set for next year.8014
Q4 202621 Jul 2026